Viewing Study NCT06118658


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2025-12-25 @ 10:01 PM
Study NCT ID: NCT06118658
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-11-07
First Post: 2023-10-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Chemotherapy Sequential Tislelizumab After Radical Resection in Patients With dMMR/MSI-H or POLE/POLD1 Mutations
Sponsor: China Medical University, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module